Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Friday, March 2, 2012 - 10:37am
tags:
earnings, Isis Pharmaceuticals, Kynamro
Genzyme gets FDA OK to ship Fabry drug
Mass High Tech
Friday, March 2, 2012 - 10:20am
tags:
FDA, Fabry's disease, Genzyme, Fabrazyme
Roger Perlmutter’s Parting Thoughts on Amgen
Xconomy
Friday, March 2, 2012 - 10:19am
tags:
Amgen, R&D, Roger Perlmutter
Chinese pharmas feel the squeeze of healthcare reform
Fierce Pharma
Friday, March 2, 2012 - 10:19am
tags:
China, healthcare reform, antibiotics
Columbia Labs to cut 42% of workforce after FDA snub
Fierce Pharma
Friday, March 2, 2012 - 10:17am
tags:
layoffs, Columbia Laboratories
LadaTech Patent Infringed by Illumina, Federal Jury Rules
Bloomberg
Friday, March 2, 2012 - 10:11am
tags:
LadaTech, patents, Illumina, GSK, gene manipulation
Charles River Laboratories International Crushes Earnings Estimates
Motley Fool
Friday, March 2, 2012 - 10:10am
tags:
earnings, Charles River Laboratories
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
TheStreet.com
Friday, March 2, 2012 - 10:10am
tags:
Cyclacel, Vivus, Celldex, Astex, Discovery Labs, Exelixis
[video] The Next Big Thing in Biotech: Discovery Labs
TheStreet.com
Friday, March 2, 2012 - 10:07am
tags:
Discovery Labs
Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Friday, March 2, 2012 - 10:07am
tags:
earnings, Anika
Teva Pharmaceutical: Dividends, Earnings And Valuation Analysis
Seeking Alpha
Friday, March 2, 2012 - 9:50am
tags:
Teva Pharmaceuticals, earnings, dividends
SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results
Yahoo/AP
Friday, March 2, 2012 - 9:49am
tags:
SciClone, head and neck cancer, SCV-07, oral mucositis
Watson launches generic version of Abbott's Prometrium
Yahoo/Fly on the Wall
Friday, March 2, 2012 - 9:48am
tags:
generics, Abbott Laboratories, Prometrium
Judge refuses to halt Amgen-Micromet deal
Yahoo/AP
Thursday, March 1, 2012 - 6:03pm
tags:
Amgen, Micromet, M&A
Durect's partner Pfizer to end pain drug deal
Reuters
Thursday, March 1, 2012 - 6:02pm
tags:
Pfizer, Durect Corporation, Eladur
Pharmacyclics Gains Ahead of Investor Call
Bloomberg
Thursday, March 1, 2012 - 5:59pm
tags:
Pharmacyclics, JNJ
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thursday, March 1, 2012 - 12:45pm
tags:
FDA, Vertex, M&A, Kalydeco, cystic fibrosis
Spectrum Pharma 4Q profit grows, but shares fall
Yahoo/AP
Thursday, March 1, 2012 - 12:44pm
tags:
Spectrum Pharmaceuticals, earnings
Endo Pharmaceuticals to Change Name to Endo Health Solutions
Bloomberg
Thursday, March 1, 2012 - 12:43pm
tags:
Endo Health Solutions, Endo
Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Thursday, March 1, 2012 - 12:42pm
tags:
Allos, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.